These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 13604035)

  • 1. [Blood supply of mouse mammary carcinoma during the developmental process].
    NATADZE TG
    Vopr Onkol; 1958; 4(3):292-5. PubMed ID: 13604035
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of spreading factors on the development of mouse mammary carcinoma].
    LACASSAGNE A; LOISELEUR J; RUDALI G
    Bull Assoc Fr Etud Cancer; 1957 Dec; 44(4):552-72. PubMed ID: 13523265
    [No Abstract]   [Full Text] [Related]  

  • 3. [The problem of appearance of mouse mammary carcinoma].
    RIABININA ZA
    Biull Eksp Biol Med; 1958 Sep; 46(9):105-7. PubMed ID: 13607542
    [No Abstract]   [Full Text] [Related]  

  • 4. Further studies on metastasis of a transplantable mouse mammary carcinoma after roentgen irradiation.
    VON ESSEN CF; KAPLAN HS
    J Natl Cancer Inst; 1952 Feb; 12(4):883-92. PubMed ID: 14908552
    [No Abstract]   [Full Text] [Related]  

  • 5. [Inverse effects of hyaluronidase and antihyaluronidase serum on the development of mammary carcinoma in the mouse].
    LACASSAGNE A; LOISELEUR J; RUDALI G
    C R Hebd Seances Acad Sci; 1957 Mar; 244(12):1587-9. PubMed ID: 13427227
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro study of a mouse mammary carcinoma simulating carsinosarcoma and sarcomatous overgrowth during transplantation.
    RINGSTED J
    Acta Pathol Microbiol Scand; 1957; 40(5):373-83. PubMed ID: 13443966
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of roentgen irradiation on the tumor bed. I. The inhibiting action of local pretransplantation roentgen irradiation (1500 r alpha) on the growth of mouse mammary carcinoma.
    STENSTROM KW; VERMUND H; MOSSER DG; MARVIN JF
    Radiat Res; 1955 Apr; 2(2):180-91. PubMed ID: 14372038
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeting angiogenesis for mammary cancer prevention: factors to consider in experimental design and analysis.
    Thompson HJ; McGinley JN; Wolfe P; Spoelstra NS; Knott KK
    Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1173-84. PubMed ID: 15247128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectins as markers of aggressiveness of mouse mammary carcinoma: towards a lectin target therapy of human breast cancer.
    Moiseeva EV; Rapoport EM; Bovin NV; Miroshnikov AI; Chaadaeva AV; Krasilshschikova MS; Bojenko VK; Bijleveld C; van Dijk JE; Den Otter W
    Breast Cancer Res Treat; 2005 Jun; 91(3):227-41. PubMed ID: 15952056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas.
    Theodorou V; Boer M; Weigelt B; Jonkers J; van der Valk M; Hilkens J
    Oncogene; 2004 Aug; 23(36):6047-55. PubMed ID: 15208658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are syngeneic mouse tumor models still valuable experimental models in the field of anti-cancer drug discovery?
    Darro F; Decaestecker C; Gaussin JF; Mortier S; Van Ginckel R; Kiss R
    Int J Oncol; 2005 Sep; 27(3):607-16. PubMed ID: 16077908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of estrogenic hormones in the process of experimental carcinogenesis of the mammary gland].
    PODIL'CHAK MD
    Neoplasma; 1961; 8():237-46. PubMed ID: 13736464
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the transmission of the mouse mammary tumor agent by the male parent.
    MUHLBOCK O
    J Natl Cancer Inst; 1952 Feb; 12(4):819-37. PubMed ID: 14908546
    [No Abstract]   [Full Text] [Related]  

  • 14. Negative chemotherapy data against transplanted solid mouse mammary carcinomas.
    GREENBERG DM; NORBERG SASSENRATH E; LARSON AM
    Cancer Res; 1955; Suppl. 2():103-8. PubMed ID: 14379184
    [No Abstract]   [Full Text] [Related]  

  • 15. [Various aspects of a mouse mammary tumor associated with different chick embryo organs in culture in vitro].
    WOLFF E; SIGOTMF
    C R Seances Soc Biol Fil; 1961; 155():960-2. PubMed ID: 14007997
    [No Abstract]   [Full Text] [Related]  

  • 16. Mammary adenocarcinoma 775, glioma 26, and Brown-Pearce carcinoma.
    GELLHORN A; KELLS A; GOLINO M
    Cancer Res; 1955; Suppl. 3():38-43. PubMed ID: 14364497
    [No Abstract]   [Full Text] [Related]  

  • 17. Local over-expression of prolactin in differentiating mouse mammary gland induces functional defects and benign lesions, but no carcinoma.
    Manhès C; Kayser C; Bertheau P; Kelder B; Kopchick JJ; Kelly PA; Touraine P; Goffin V
    J Endocrinol; 2006 Aug; 190(2):271-85. PubMed ID: 16899561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the responses of normal, precancerous, and neoplastic mouse mammary tissues to hormones in vitro.
    ELIAS JJ; RIVERA E
    Cancer Res; 1959 Jun; 19(5):505-11. PubMed ID: 13663038
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ.
    Namba R; Young LJ; Abbey CK; Kim L; Damonte P; Borowsky AD; Qi J; Tepper CG; MacLeod CL; Cardiff RD; Gregg JP
    Clin Cancer Res; 2006 Apr; 12(8):2613-21. PubMed ID: 16638874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of integrin signaling in genetically engineered mouse models of mammary tumor progression.
    Pylayeva Y; Guo W; Giancotti FG
    Methods Enzymol; 2007; 426():439-61. PubMed ID: 17697895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.